Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer

NCT01888042 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: Everolimus

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris